Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-07-29 02:02 UTC

BIOMED PULSE

Daily Briefing on Longevity, Viruses & New Cures

Tuesday, July 29, 2026

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in DRC and Uganda has now reached 2,124 confirmed cases and 828 deaths as of July 15, making it the dominant global health emergency of 2026. [1] Alongside Ebola, a Cyclospora outbreak tied to Taco Bell shredded iceberg lettuce has sickened 1,644 people across at least nine U.S. states, and WHO's new dementia guidelines offer rare good news: up to 45% of dementia risk may be preventable. [2] [3]

🦠 OUTBREAKS & VIRUSES

EBOLA BUNDIBUGYO VIRUS - DRC AND UGANDA (CRITICAL)

  • As of July 15, 2026, WHO confirmed 2,124 cases and 828 deaths from Bundibugyo virus disease (BVD) in DRC, with ongoing cross-border transmission into Uganda. [1]
  • The PARTNERS clinical trial, backed by WHO, opened patient enrolment on July 2 in DRC to evaluate the first potential treatments specifically for Bundibugyo virus disease. [4]
  • WHO added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing on July 2, enabling faster and more accurate blood-sample confirmation. [5]
  • Africa CDC and WHO previously launched a joint continental Ebola response plan on June 5 targeting US$518 million to support African countries' preparedness. [6]
  • WHO issued its first comprehensive clinical management guidelines for all filovirus diseases, covering all Ebola types and Marburg, in direct response to the DRC outbreak on June 17. [7]
  • CDC mobilized enhanced airport Ebola screening at Washington-Dulles and later expanded it to Atlanta, with screening focusing on travelers arriving from affected regions. [8] [9]

CYCLOSPORA - TACO BELL / ICEBERG LETTUCE

  • Shredded iceberg lettuce served at Taco Bell locations is the confirmed source of a Cyclospora cayetanensis outbreak, with 1,644 people sick across five states as of July 17. [2]
  • The outbreak has since expanded to four additional states, CDC confirmed on July 24. [10]
  • CDC held a dedicated Cyclosporiasis Response briefing on July 14 as case counts climbed.

NIPAH VIRUS - INDIA

  • On June 11, Kerala State, India confirmed a laboratory case of Nipah virus (NiV) infection in an adult male in Kozhikode district; symptoms began May 30 and included neurological features.
  • A separate NiV case was confirmed in Rajshahi Division, Bangladesh in early February 2026, signaling continued endemic circulation of this paramyxovirus in South Asia.

MPOX - RECOMBINANT STRAIN

  • WHO documented a recombinant monkeypox virus (MPXV) strain combining genomic elements of both clade Ib and clade IIb in two cases, a natural but concerning process that occurs when two strains co-infect a single host.

HANTAVIRUS - M/V HONDIUS CRUISE SHIP

  • The Andes hantavirus (ANDV) cluster linked to the M/V Hondius cruise ship, first reported to WHO on May 2, has been the subject of five Disease Outbreak News reports; as of the July 2 update it remains active across multiple countries.
  • CDC held multiple Hantavirus response briefings through late June, with the risk to the general American public described as extremely low.

WEST NILE VIRUS - UNITED STATES

  • CDC on July 1 warned of an early West Nile season with record case counts, urging mosquito-bite prevention through the Independence Day holiday weekend.

AVIAN INFLUENZA H9N2 - ITALY

  • WHO on April 10 reported a human case of influenza A(H9N2) in Italy in an adult male who had returned from Senegal, confirmed by next-generation sequencing.

YELLOW FEVER - GLOBAL

  • From January 1 to May 26, 2026, six countries reported 79 human yellow fever infections; transmission carried over from elevated 2025 activity in the Americas, per WHO.

E. COLI - FROZEN BLUEBERRIES

  • CDC on July 7 issued a food safety alert warning consumers not to eat recalled frozen blueberries linked to a multistate E. coli outbreak.

🧬 LONGEVITY & AGING

DEMENTIA RISK REDUCTION - WHO GUIDELINES

  • WHO released updated evidence-based guidelines on July 15 stating that up to 45% of dementia risk could be prevented or delayed through modifiable risk factors addressed across the life course. [3]
  • The guidelines provide countries with actionable recommendations targeting cardiovascular health, physical activity, social engagement, and education as protective factors against cognitive decline. [3]

NAD+ HOMEOSTASIS AND BONE REPAIR

  • A Europe PMC study (Bioactive Materials, June 27) describes a senescent metabolism-modulating hierarchical scaffold that restores NAD+ homeostasis and redox balance specifically in aged bone tissue, demonstrating a new materials-based approach to overcoming senescence-related repair failure.

KAEMPFEROL FROM MORINGA AND LONGEVITY

  • A Toxicology Reports study (June 25) found that kaempferol, a flavonoid derived from Moringa oleifera L., increased longevity and ameliorated efavirenz-induced functional senescence in a Drosophila melanogaster model, linking a common plant compound to anti-senescence pathways.

TELOMERE REPAIR AND NUCLEAR BODIES

  • Research published in Nucleus (July 23) examined repair and misrepair of telomeric DNA in dynamic interactions with PML nuclear bodies and lamin B1 in doxorubicin-treated cancer cells, shedding light on how the nuclear architecture governs genomic stability in stressed aging cells.

TAU AND NUCLEAR MECHANOTRANSDUCTION

  • A Nucleus study (July 7) found that elevation of the mechanically sensitive nuclear envelope protein emerin links nuclear mechanotransduction to tau-induced cytoskeletal remodeling in neurons, connecting physical nuclear stress to Alzheimer's-related tau pathology.

COLLAGEN XVII AND SKIN PHOTOAGING

  • Research in Annals of Medicine (July 16) showed that recombinant human collagen XVII protects epidermal stem cells from blue light-induced photoaging by downregulating the Notch signaling pathway, a potential target for skin longevity interventions.

HYPERTENSION AND FRAILTY IN OLDER ADULTS

  • A letter in Blood Pressure (July 7) highlighted evidence from the Longitudinal Ageing Study in India associating hypertension with frailty among middle-aged and older adults, reinforcing cardiovascular control as a frailty-prevention strategy.

CANCER BURDEN PROJECTIONS

  • WHO on July 8 projected that new global cancer cases will nearly double by 2050 from a current base of 20.6 million new cases and close to 10 million deaths annually, urging urgent early-detection and prevention investment.

p16-INK4A SENESCENCE MARKER VALIDATION

  • A study in Islets (July 21) addressed antibody validation challenges in detecting cell cycle regulatory protein p16-INK4A by immunohistochemistry in pancreatic tissue, a technically critical step for accurate senescence research in metabolic disease.

METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND TOBACCO

  • A Journal of Diabetes and Metabolic Disorders study (July 3) analyzed the global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) attributable to tobacco from 1990 to 2023 and projected trends to 2038, quantifying tobacco as a modifiable driver of liver aging.

RESPIRATORY MUSCLE TRAINING AND COGNITION IN OLDER ADULTS

  • A ClinicalTrials.gov study (NCT07728279, registered July 28, 2026) is evaluating the impact of inspiratory muscle training (IMT) on cognitive outcomes in older adults, building on IMT's established rehabilitation use and its potential brain-perfusion benefits.

💊 NEW CURES & APPROVALS

  • LYTENAVA (bevacizumab-vikg), sponsored by Outlook Therapeutics Inc., received an original FDA approval (BLA761320) as an anti-VEGF biologic; this is the ophthalmic formulation of bevacizumab targeting retinal neovascular disease.
  • SIMTRIYO (centanafadine), sponsored by Otsuka Pharmaceutical Co. Ltd., received an original FDA approval (NDA218145); centanafadine is a triple reuptake inhibitor of norepinephrine, dopamine, and serotonin indicated for ADHD.
  • REZDIFFRA (resmetirom), by Madrigal Pharmaceuticals, received a supplemental FDA approval (NDA217785); resmetirom is a liver-targeted thyroid hormone receptor beta agonist for metabolic dysfunction-associated steatohepatitis (MASH).
  • XTANDI (enzalutamide), by Astellas, received supplemental approvals on both NDA203415 and NDA213674, reflecting expanded indications for this androgen receptor inhibitor used in prostate cancer.
  • BREXAFEMME (ibrexafungerp citrate), by GlaxoSmithKline, received a supplemental approval (NDA214900); ibrexafungerp is a first-in-class triterpenoid antifungal that inhibits glucan synthase, used for vulvovaginal candidiasis.
  • TYLENOL WITH NAPROXEN, sponsored by Kenvue Brands LLC, received an original FDA approval (NDA219962) combining naproxen sodium and acetaminophen as a dual-mechanism OTC analgesic.

🧪 CLINICAL TRIALS

LONG COVID NEUROLOGICAL SYMPTOMS - PEMBROLIZUMAB (PD-1 INHIBITOR)

  • A Phase I open-label safety trial (NCT07388550) is testing pembrolizumab, an anti-PD-1 checkpoint inhibitor, in patients with neurological post-acute sequelae of SARS-CoV-2 (neuro-PASC), based on the hypothesis that persistent immune checkpoint activation drives long COVID symptoms.

MYELOMA - MIRDAMETINIB PLUS SIROLIMUS

  • A trial (NCT06876142) is enrolling patients with RAS-mutated relapsed/refractory multiple myeloma (RRMM) to test combination therapy with mirdametinib (MEK inhibitor) and sirolimus (mTOR inhibitor), targeting the KRAS/NRAS mutation pathway that drives resistance.

NEOADJUVANT LUNG CANCER - INHALED AZACYTIDINE PLUS DURVALUMAB

  • Trial NCT06694454 (AZA-AEGEAN) is testing inhaled azacytidine (epigenetic agent) combined with platinum-based chemotherapy and the anti-PD-L1 antibody durvalumab (MEDI4736) as neoadjuvant therapy for operable early-stage non-small cell lung cancer (NSCLC).

COGNITION SUPPLEMENTATION IN OLDER ADULTS

  • Trial NCT06767124 (Supplementing Neuro-Energy to Aid Cognition) is targeting age-related cognitive decline through metabolic brain energy support, motivated by projections that 1 in 5 Americans will be retirement age by 2030.

AI-ASSISTED ECHOCARDIOGRAPHY IN GERIATRIC PATIENTS

  • Trial NCT07701369 is evaluating artificial intelligence-assisted echocardiography for left ventricular ejection fraction assessment in adults aged 80 and older, where heart failure is the leading cause of hospitalization and typical clinical presentations are frequently atypical.

ATRIAL FIBRILLATION IN OLDER RURAL PATIENTS - CHINA

  • Trial NCT07492498 is running a cluster randomized study comparing village doctor-led integrated care versus usual care to prevent heart failure and improve atrial fibrillation management in older rural patients in China.

ARTEMISININ RESISTANCE - TRIPLE COMBINATION THERAPY

  • Trial NCT05764746 is testing triple artemisinin-based combination therapy (ACT) to delay drug resistance development in Plasmodium falciparum malaria, addressing emerging artemisinin resistance in Southeast Asia and Africa.

📢 PUBLIC HEALTH

MEASLES - BANGLADESH NATIONWIDE SURGE

  • Bangladesh reported 19,161 suspected measles cases and 2,897 laboratory-confirmed cases across 58 of 64 districts and all eight divisions as of the WHO Disease Outbreak News report on April 23, 2026.

GLOBAL IMMUNIZATION COVERAGE 2025

  • In 2025, 90% of infants globally (about 116 million) received at least one DTP dose, and 85% (110 million) completed the full three-dose series, per WHO-UNICEF WUENIC data released July 15.

CDC HEALTHCARE-ASSOCIATED INFECTIONS DECLINE

  • CDC released data on July 15 showing a decline in hospital-acquired infections in 2023, attributed to improved infection prevention practices across U.S. facilities.

DRUG-RESISTANT SALMONELLA - MORINGA PRODUCTS

  • An extensively drug-resistant Salmonella outbreak linked to moringa powder capsules has been ongoing since at least February 2026, with three hospitalizations reported; the outbreak grew to 65 people in 28 states by January 29 in a prior linked strain.

CYCLOSPORA - TACO BELL CONSUMER ACTION

  • Consumers in affected states should avoid Taco Bell shredded iceberg lettuce products; the outbreak has already reached 1,644 illnesses and continues to spread. [2] [10]

UNSAFE FOOD GLOBAL BURDEN

  • WHO estimated on June 3 that unsafe food causes 866 million illnesses and 1.5 million deaths annually worldwide, with children under five facing nearly three times the risk of illness compared with older children and adults.

TRAVEL-RELATED COSMETIC PROCEDURES RISK

  • CDC on June 2 highlighted adverse health outcomes linked to travel-related cosmetic procedures, urging consumers to be aware of infection and complication risks when seeking procedures abroad.

NEW WORLD SCREWWORM RESPONSE

  • CDC activated its Emergency Operations Center on June 12 for response to New World Screwworm (Cochliomyia hominivorax), a parasitic fly larvae that can infest wounds in humans and animals.

INFANT BOTULISM - FORMULA RECALL

  • CDC on June 13 urged parents to immediately stop using Nara Organics Whole Milk Organic Infant Formula, linked to an infant botulism outbreak that CDC solved through rapid response investigation.

TICK BITES - ELEVATED SEASON

  • CDC data released April 23 showed weekly emergency department visits for tick bites are running higher than usual in 2026; Lyme and other tickborne diseases have been an increasing threat since at least 2019.

This briefing is informational only and does not constitute medical advice. Always consult a qualified healthcare professional for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. Shredded iceberg lettuce served at Taco Bell locations is sour… — CDC Newsroom
  3. New WHO guidelines: up to 45% of dementia risk could be preven… — WHO News
  4. Patient enrolment begins in a scientific trial to identify the… — WHO News
  5. WHO adds first diagnostic test for Ebola Bundibugyo virus to i… — WHO News
  6. Africa CDC and WHO launch joint continental Ebola response plan — WHO News
  7. WHO issues comprehensive guidelines on filovirus disease, incl… — WHO News
  8. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  9. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  10. Cyclospora outbreak linked to iceberg lettuce expanded to four… — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260729-02-v42 · 2026-07-29 02:02 UTC · pulse.uzylab.com

Read next